Clinical trial
Stem Cells in Rapidly Evolving Active Multiple Sclerosis
NCT01606215 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stem Cells in Rapidly Evolving Active Multiple Sclerosis
- Lead sponsor
- Imperial College London
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- August 31, 2019
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.